Kazia Therapeutics Limited
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Kazia Therapeutics Limited's past years’ income statements indicate that its last revenue has increased compared to the previous period by 415756% to $2,308,000. Profit margin reached -1160%. Total operating expenses were $2,308,000.

Profit Margin

Kazia Therapeutics Limited (NASDAQ:KZIA): Profit margin
2015 89K -7.13M -8020.89%
2016 4.07M -12.06M -296.29%
2017 8.78M -10.67M -121.42%
2018 13.10K -6.03M -46071.1%
2019 1.56K -10.27M -656230.03%
2020 1.06K -12.46M -1175023.56%
2021 15.18M -8.42M -55.47%
2022 25 -24.64M -98591260%
2023 555 -20.46M -3687419.82%
2024 2.30M -26.77M -1160.23%

KZIA Income Statement (2015 – 2024)

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
2.30M5552515.18M1.06K1.56K13.10K8.78M4.07M89K
Cost of revenue
0000000000
Gross profit
2.30M5552515.18M1.06K1.56K13.10K8.78M4.07M89K
Operating exp.
Research and development
17.38M15.56M20.25M14.54M9.49M6.47M9.77M11.13M9.89M5.93M
Selling and marketing
00127.04K0000000
Total operating expenses
2.30M24.12M24.88M24.13M13.16M10.25M14.68M19.65M15.63M9.68M
Operating income
0-24.12M-26.69M-6.37M-12.52M-8.38M-12.48M-10.85M-12.77M-8.14M
Other income (expenses), net
-27.04M3.38M1.68M-2.52M-569.57K-2.18M8.22M7.87K3.07M754.78K
Income before tax
-27.04M-20.73M-25.01M-8.90M-12.76M-10.56M-6.34M-10.86M-12.15M-7.30M
Income tax expense
-271K271.09K-368.08K484.34K-298K-298K-305K198.54K2.77M1.43M
Net income
-26.77M-20.46M-24.64M-8.42M-12.46M-10.27M-6.03M-10.67M-12.06M-7.13M
Earnings per share
Basic EPS
0-1.12-1.86-0.07-1.71-1.79-1.25-2.28-2.82-2.99
Diluted EPS
0-1.11-1.86-0.07-1.71-1.79-1.25-2.28-2.82-2.99
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source